| Primary |
| Drug Use For Unknown Indication |
100.0% |
|
| Asthenia |
33.3% |
| Drug Withdrawal Syndrome |
33.3% |
| Restlessness |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
47.6% |
| Drug Use For Unknown Indication |
8.1% |
| Schizophrenia |
6.9% |
| Myelitis Transverse |
5.1% |
| Neuralgia |
4.6% |
| Psychotic Disorder |
3.7% |
| Major Depression |
3.5% |
| Acute Psychosis |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Bipolar Disorder |
2.1% |
| Depression |
2.1% |
| Pain |
2.1% |
| Suicide Attempt |
1.8% |
| Cardiomyopathy |
1.2% |
| Schizophrenia, Paranoid Type |
1.2% |
| Anaesthesia |
0.9% |
| Agitation |
0.7% |
| Back Pain |
0.7% |
| Insomnia |
0.7% |
| Staphylococcal Infection |
0.7% |
|
| Completed Suicide |
20.3% |
| Toxicity To Various Agents |
12.2% |
| Drug Withdrawal Syndrome |
10.8% |
| Tracheo-oesophageal Fistula |
10.8% |
| Death |
5.4% |
| Tremor |
5.4% |
| Neuroleptic Malignant Syndrome |
4.1% |
| Respiratory Arrest |
4.1% |
| Restlessness |
4.1% |
| Somatoform Disorder Pregnancy |
4.1% |
| Maternal Exposure During Pregnancy |
2.7% |
| Suicide Attempt |
2.7% |
| Tachycardia |
2.7% |
| Treatment Noncompliance |
2.7% |
| Abortion Spontaneous |
1.4% |
| Blood Cholesterol |
1.4% |
| Cerebrovascular Accident |
1.4% |
| Drug Toxicity |
1.4% |
| Drug Withdrawal Syndrome Neonatal |
1.4% |
| Exposure During Pregnancy |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.3% |
| Anxiety |
17.1% |
| Depression |
15.5% |
| Schizophrenia |
11.2% |
| Drug Use For Unknown Indication |
6.0% |
| Bipolar Disorder |
4.4% |
| Cardiomyopathy |
4.0% |
| Psychotic Disorder |
3.2% |
| Mania |
2.8% |
| Schizophrenia, Paranoid Type |
2.4% |
| Epilepsy |
1.6% |
| Hypertension |
1.6% |
| Neuralgia |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Gout |
1.2% |
| Myelitis Transverse |
1.2% |
| Obesity |
1.2% |
| Pain |
1.2% |
| Unevaluable Event |
1.2% |
| Major Depression |
0.8% |
|
| Weight Increased |
16.4% |
| Type 2 Diabetes Mellitus |
9.8% |
| Vision Blurred |
8.2% |
| Withdrawal Syndrome |
8.2% |
| Treatment Noncompliance |
6.6% |
| Vasculitic Rash |
6.6% |
| Psychotic Disorder |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Acute Psychosis |
3.3% |
| Catatonia |
3.3% |
| Drug Withdrawal Syndrome |
3.3% |
| Loss Of Consciousness |
3.3% |
| Neuroleptic Malignant Syndrome |
3.3% |
| Somnolence |
3.3% |
| Thrombosis |
3.3% |
| Tremor |
3.3% |
| Urinary Tract Infection |
3.3% |
| Cervix Carcinoma Stage 0 |
1.6% |
| Completed Suicide |
1.6% |
| Diarrhoea |
1.6% |
|
